Online citations, reference lists, and bibliographies.
← Back to Search

The MARS Trial: Mesothelioma And Radical Surgery.

T. Treasure, Carol Tan, L. Lang-Lazdunski, D. Waller
Published 2006 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
The increasing incidence of malignant pleural mesothelioma has demanded the attention of thoracic surgeons worldwide. Can radical surgery cure mesothelioma or add usefully to the length and quality of life for its victims? The MARS (mesothelioma and radical surgery) trial is open and recruiting in Britain. If the trial proves feasible we will seek to make an international study.
This paper references



This paper is referenced by
10.1016/j.crad.2009.03.010
CT appearances of pleural tumours.
H. Salahudeen (2009)
10.1016/j.lungcan.2008.04.001
The efficacy and safety of weekly vinorelbine in relapsed malignant pleural mesothelioma.
J. Stebbing (2009)
10.1510/icvts.2010.258301
Lack of evidence in malignant pleural mesothelioma surgery.
O. Rena (2011)
10.2174/9781681081946116010023
PROGNOSTIC FACTORS IN MALIGNANT PLEURAL MESOTHELIOMA
Tommaso Claudio Mineo and Vincenzo Ambrogi (2016)
10.1186/1750-1172-3-34
Malignant mesothelioma
A. Moore (2008)
10.1097/JTO.0b013e3181e95cb8
Prognostic Factors for Survival after Surgical Palliation of Malignant Pleural Effusion
John E Pilling (2010)
10.1016/j.ijrobp.2007.11.011
Intensity-modulated radiotherapy for resected mesothelioma: the Duke experience.
E. Miles (2008)
10.1016/J.EJCTS.2006.11.046
A phase II study of intrapleural immuno-chemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy and long-term sub-cutaneous IL-2 in stage II-III malignant pleural mesothelioma.
M. Lucchi (2007)
10.3109/0284186X.2012.709948
Treatment and survival analyses of malignant mesothelioma in Japan
K. Gemba (2013)
10.1308/003588407X232198
Pulmonary metastasectomy: a common practice based on weak evidence.
T. Treasure (2007)
10.1016/j.cllc.2014.06.009
Correlation between TS, MTHFR, and ERCC1 gene polymorphisms and the efficacy of platinum in combination with pemetrexed first-line chemotherapy in mesothelioma patients.
T. Powrózek (2014)
10.1378/chest.08-2665
Malignant pleural mesothelioma: an update on biomarkers and treatment.
M. Ray (2009)
10.4997/JRCPE.2012.107
Malignant mesothelioma presenting as a breast mass.
A. Aujayeb (2012)
10.1097/MCP.0b013e328302851d
Malignant mesothelioma 2008
M. Zervos (2008)
10.1510/icvts.2009.223255
Multimodality treatment of malignant pleural mesothelioma with or without immunotherapy: does it change anything?
M. Lucchi (2010)
10.1097/MCP.0b013e3283474121
The diminishing role of surgery in pleural disease
H. E. Davies (2011)
Orphanet Journal of Rare Diseases Malignant Mesothelioma Disease Name and Definition Epidemiology and Aetiology
Alastair J. Moore ()
10.1016/J.EJCTS.2006.10.008
The evidence on which to base practice: Different tools for different times.
T. Treasure (2006)
10.1016/j.ctrv.2012.03.001
An overview of neoadjuvant chemotherapy in the multimodality treatment of malignant pleural mesothelioma.
G. Pasello (2013)
10.1002/cncr.24108
A possible association between aprotinin and improved survival after radical surgery for mesothelioma
P. Norman (2009)
PROGNOSTIC FACTORS IN MALIGNANT PLEURAL MESOTHELIOMA
FATTORI PROGNOSTICI (2012)
10.1097/JTO.0b013e3181cbf465
Role of Integrated 18-Fluorodeoxyglucose Position Emission Tomography-Computed Tomography in Patients Surveillance after Multimodality Therapy of Malignant Pleural Mesothelioma
C. Tan (2010)
10.1586/17476348.1.3.335
Surgery for lung metastases from colorectal cancer: the practice examined
T. Treasure (2007)
10.2482/HAIGAN.49.248
Outcome of Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma
Toshikazu Yusa (2009)
10.5772/47880
Neoadjuvant Chemotherapy in Malignant Pleural Mesothelioma
G. Pasello (2012)
10.1136/thoraxjnl-2013-204110
Systemic but not topical TRAIL-expressing mesenchymal stem cells reduce tumour growth in malignant mesothelioma
E. Sage (2014)
An Update on Biomarkers and Treatment
Mandira Ray (2015)
10.1016/j.ejcts.2009.08.016
Surgery for mesothelioma: MARS landing and future missions.
T. Treasure (2010)
10.1097/JTO.0B013E318156AF3B
Mesothelioma: benefit from surgical resection is questionable.
T. Treasure (2007)
10.1016/j.anndiagpath.2008.11.001
Surgery for malignant pleural mesothelioma.
D. Rice (2009)
10.1007/978-3-642-10862-4_7
Surgical therapy of mesothelioma.
D. Rice (2011)
10.1183/09031936.00207213
Multimodal management of malignant pleural mesothelioma: where are we today?
P. V. Van Schil (2014)
See more
Semantic Scholar Logo Some data provided by SemanticScholar